News

Pfizer and BioNTech ask FDA to authorize omicron-specific COVID-19 booster

By Abigail Adcox
Published August 22, 2022 3:35pm ET
Add Washington Examiner on Google
Pfizer and BioNTech ask FDA to authorize omicron-specific COVID-19 booster
Pfizer and BioNTech announced Monday that they have submitted a bivalent COVID-19 booster to the Food and Drug Administration for emergency use authorization for people ages 12 and older. The updated vaccine formula is targeted to provide protection against both the original COVID-19 virus from 2020 and omicron subvariants BA.4 and BA.5 following a recommendation […]

Pfizer and BioNTech announced Monday that they have submitted a bivalent COVID-19 booster to the Food and Drug Administration for emergency use authorization for people ages 12 and older.

Already a print subscriber? Click here to login/register your account

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.

Tag:

Biden Administration Department of Health and Human Services Doctors Health Insurance